Skip to main content
Erschienen in: Rheumatology International 10/2012

01.10.2012 | Original Article

Combined influence of genetic and environmental factors in age of rheumatoid arthritis onset

verfasst von: Luis Rodríguez-Rodríguez, José Ramón Lamas, Jezabel Varadé, Pilar Tornero-Esteban, Lydia Abasolo, Emilio Gomez de la Concha, Juan Angel Jover, Elena Urcelay, Benjamín Fernández-Gutiérrez

Erschienen in: Rheumatology International | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

To study the combined effect of both genetic and environmental factors in the age of rheumatoid arthritis onset. Patients (n = 507). Shared epitope characterization was performed using Lifecodes HLA-SSO. Genotyping of protein tyrosine phosphatase non-receptor 22 (PTPN22) rs2476601 and signal transducers and activators of transcription 4 (STAT4) rs7574865 polymorphism was performed using fast real-time PCR System. Shared epitope, antibodies directed against cyclic citrulinated peptide (anti-CCP) antibodies and a higher level of education were associated with a younger age at disease onset (P = 0.033, P = 0.004 and P < 0.0001, respectively). Neither carriers of the minor allele of PTPN22 rs2476601 nor STAT4 rs7574 polymorphisms showed a significant association with a younger age at disease onset (P = 0.355, P = 0.065, respectively). We found an additive effect of the three genetic markers in the age at onset: subjects with three markers were associated with a disease onset 9.56, 8.61, and 6.41 years before than those with none, one, or two genetic markers (P = 0.004, P = 0.006 and P = 0.043, respectively). We also described the additive effect of shared epitope, anti-CCP antibodies, educational level, PTPN22, and STAT4 polymorphisms in age at onset. Patients with two, three, four, or five variables were associated with a significant younger age of disease onset (4.72 [0.05–9.38] years (P = 0.048), 9.56 [4.72–14.40] years (P < 0.0001), 12.74 [6.84–18.64] years (P < 0.0001), and 20.87 [10.40–37.17] years (P < 0.0001)). Risk factors for the development of rheumatoid arthritis are also associated, with an additive effect, with a younger age at disease onset.
Literatur
2.
Zurück zum Zitat MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K et al (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43:30–37PubMedCrossRef MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K et al (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43:30–37PubMedCrossRef
3.
Zurück zum Zitat Imboden JB (2009) The immunopathogenesis of rheumatoid arthritis. Annu Rev Pathol 4:417–434PubMedCrossRef Imboden JB (2009) The immunopathogenesis of rheumatoid arthritis. Annu Rev Pathol 4:417–434PubMedCrossRef
4.
Zurück zum Zitat Newton JL, Harney SM, Wordsworth BP, Brown MA (2004) A review of the MHC genetics of rheumatoid arthritis. Genes Immun 5:151–157PubMedCrossRef Newton JL, Harney SM, Wordsworth BP, Brown MA (2004) A review of the MHC genetics of rheumatoid arthritis. Genes Immun 5:151–157PubMedCrossRef
5.
Zurück zum Zitat MacKay K, Eyre S, Myerscough A, Milicic A, Barton A, Laval S et al (2002) Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum 46:632–639PubMedCrossRef MacKay K, Eyre S, Myerscough A, Milicic A, Barton A, Laval S et al (2002) Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum 46:632–639PubMedCrossRef
6.
Zurück zum Zitat MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A (1995) HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol 22:1032–1036PubMed MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A (1995) HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol 22:1032–1036PubMed
7.
Zurück zum Zitat Hellier J, Eliaou J, Daures J, Sany J, Combe B (2001) HLA-DRB1 genes and patients with late onset rheumatoid artritis. Ann Rheum Dis 60:531–533PubMedCrossRef Hellier J, Eliaou J, Daures J, Sany J, Combe B (2001) HLA-DRB1 genes and patients with late onset rheumatoid artritis. Ann Rheum Dis 60:531–533PubMedCrossRef
8.
Zurück zum Zitat Wu H, Khanna D, Park G, Gersuk V, Nepom GT, Wong WK, Paulus HE, Tsao BP (2004) Interaction between RANKL and HLA-DRB1 genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort. Arthritis Rheum 50:3093–3103PubMedCrossRef Wu H, Khanna D, Park G, Gersuk V, Nepom GT, Wong WK, Paulus HE, Tsao BP (2004) Interaction between RANKL and HLA-DRB1 genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort. Arthritis Rheum 50:3093–3103PubMedCrossRef
9.
Zurück zum Zitat Stavropoulos C, Spyropoulou M, Koumantaki Y, Kappou I, Kaklamanis PV, Linos A, Giziaki E, Kaklamani E (1997) HLA-DRB1* genotypes in Greek rheumatoid arthritis patients: association with disease characteristics, sex and age at onset. Br J Rheumatol 36:141–142PubMedCrossRef Stavropoulos C, Spyropoulou M, Koumantaki Y, Kappou I, Kaklamanis PV, Linos A, Giziaki E, Kaklamani E (1997) HLA-DRB1* genotypes in Greek rheumatoid arthritis patients: association with disease characteristics, sex and age at onset. Br J Rheumatol 36:141–142PubMedCrossRef
10.
Zurück zum Zitat The Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447:661–678CrossRef The Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447:661–678CrossRef
11.
Zurück zum Zitat Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK et al (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases–a meta-analysis. Rheumatology (Oxford) 46:49–56CrossRef Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK et al (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases–a meta-analysis. Rheumatology (Oxford) 46:49–56CrossRef
12.
Zurück zum Zitat Steer S, Lad B, Grumley JA, Kingsley GH, Fisher SA (2005) Association of R602W in a protein tyrosine phosphatase gene with a high risk of rheumatoid arthritis in a British population: evidence for an early onset/disease severity effect. Arthritis Rheum 52:358–360PubMedCrossRef Steer S, Lad B, Grumley JA, Kingsley GH, Fisher SA (2005) Association of R602W in a protein tyrosine phosphatase gene with a high risk of rheumatoid arthritis in a British population: evidence for an early onset/disease severity effect. Arthritis Rheum 52:358–360PubMedCrossRef
13.
Zurück zum Zitat Cohen S, Dadi H, Shaoul E, Sharfe N, Roifman CM (1999) Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 93:2013–2024PubMed Cohen S, Dadi H, Shaoul E, Sharfe N, Roifman CM (1999) Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 93:2013–2024PubMed
14.
Zurück zum Zitat Cloutier JF, Veillette A (1999) Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 189:111–121PubMedCrossRef Cloutier JF, Veillette A (1999) Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 189:111–121PubMedCrossRef
15.
Zurück zum Zitat Kokkonen H, Johansson M, Innala L, Jidell E, Rantapää-Dahlqvist S (2007) The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Res Ther 9:R56PubMedCrossRef Kokkonen H, Johansson M, Innala L, Jidell E, Rantapää-Dahlqvist S (2007) The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Res Ther 9:R56PubMedCrossRef
16.
Zurück zum Zitat Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW et al (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357:977–986PubMedCrossRef Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW et al (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357:977–986PubMedCrossRef
17.
Zurück zum Zitat Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J et al (2008) Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility. Hum Mol Genet 17:2274–2279PubMedCrossRef Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J et al (2008) Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility. Hum Mol Genet 17:2274–2279PubMedCrossRef
18.
Zurück zum Zitat Horvath CM (2000) STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 25:496–502PubMedCrossRef Horvath CM (2000) STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 25:496–502PubMedCrossRef
19.
Zurück zum Zitat Korman BD, Kastner DL, Gregersen PK, Remmers EF (2008) STAT4: genetics, mechanisms, and implications for autoimmunity. Curr Allergy Asthma Rep 8:398–403PubMedCrossRef Korman BD, Kastner DL, Gregersen PK, Remmers EF (2008) STAT4: genetics, mechanisms, and implications for autoimmunity. Curr Allergy Asthma Rep 8:398–403PubMedCrossRef
20.
Zurück zum Zitat Walker JG, Ahern MJ, Coleman M, Weedon H, Papangelis V, Beroukas D et al (2006) Expression of Jak3, STAT1, STAT4, and STAT6 in inflammatory arthritis: unique Jak3 and STAT4 expression in dendritic cells in seropositive rheumatoid arthritis. Ann Rheum Dis 65:149–156PubMedCrossRef Walker JG, Ahern MJ, Coleman M, Weedon H, Papangelis V, Beroukas D et al (2006) Expression of Jak3, STAT1, STAT4, and STAT6 in inflammatory arthritis: unique Jak3 and STAT4 expression in dendritic cells in seropositive rheumatoid arthritis. Ann Rheum Dis 65:149–156PubMedCrossRef
21.
Zurück zum Zitat Lee HS, Remmers EF, Le JM, Kastner DL, Bae SC, Gregersen PK (2007) Association of STAT4 with rheumatoid arthritis in the Korean population. Mol Med 13:455–460PubMed Lee HS, Remmers EF, Le JM, Kastner DL, Bae SC, Gregersen PK (2007) Association of STAT4 with rheumatoid arthritis in the Korean population. Mol Med 13:455–460PubMed
22.
Zurück zum Zitat Kastbom A, Strandberg G, Lindroos A, Skogh T (2004) Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 63:1085–1089PubMedCrossRef Kastbom A, Strandberg G, Lindroos A, Skogh T (2004) Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 63:1085–1089PubMedCrossRef
23.
Zurück zum Zitat Varadé J, Loza-Santamaría E, Fernández-Arquero M, Lamas JR, de Los Angeles Figueredo M, Jover JA et al (2009) Shared epitope and anti-cyclic citrullinated peptide antibodies: relationship with age at onset and duration of disease in rheumatoid arthritis. J Rheumatol 36:1085–1086PubMedCrossRef Varadé J, Loza-Santamaría E, Fernández-Arquero M, Lamas JR, de Los Angeles Figueredo M, Jover JA et al (2009) Shared epitope and anti-cyclic citrullinated peptide antibodies: relationship with age at onset and duration of disease in rheumatoid arthritis. J Rheumatol 36:1085–1086PubMedCrossRef
24.
Zurück zum Zitat van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 7:R949PubMedCrossRef van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 7:R949PubMedCrossRef
25.
Zurück zum Zitat Pedersen M, Jacobsen S, Klarlund M, Frisch M (2006) Socioeconomic status and risk of rheumatoid arthritis: a Danish case-control study. J Rheumatol 33:1069–1074PubMed Pedersen M, Jacobsen S, Klarlund M, Frisch M (2006) Socioeconomic status and risk of rheumatoid arthritis: a Danish case-control study. J Rheumatol 33:1069–1074PubMed
26.
Zurück zum Zitat Bengtsson C, Nordmark B, Klareskog L, Lundberg I, Alfredsson L, EIRA Study Group (2005) Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 64:1588–1594PubMedCrossRef Bengtsson C, Nordmark B, Klareskog L, Lundberg I, Alfredsson L, EIRA Study Group (2005) Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 64:1588–1594PubMedCrossRef
27.
Zurück zum Zitat Pincus T (2007) Patient questionnaires and formal education as more significant prognostic markers than radiographs or laboratory tests for rheumatoid arthritis mortality–limitations of a biomedical model to predict long-term outcomes. Bull NYU Hosp Jt Dis 65(Suppl 1):S29–S36PubMed Pincus T (2007) Patient questionnaires and formal education as more significant prognostic markers than radiographs or laboratory tests for rheumatoid arthritis mortality–limitations of a biomedical model to predict long-term outcomes. Bull NYU Hosp Jt Dis 65(Suppl 1):S29–S36PubMed
28.
Zurück zum Zitat Pincus T, Keysor J, Sokka T, Krishnan E, Callahan LF (2004) Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practices. J Rheumatol 31:229–234PubMed Pincus T, Keysor J, Sokka T, Krishnan E, Callahan LF (2004) Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practices. J Rheumatol 31:229–234PubMed
29.
Zurück zum Zitat Vliet Vlieland TP, Buitenhuis NA, van Zeben D, Vandenbroucke JP, Breedveld FC, Hazes JM (1994) Sociodemographic factors and the outcome of rheumatoid arthritis in young women. Ann Rheum Dis 53:803–806PubMedCrossRef Vliet Vlieland TP, Buitenhuis NA, van Zeben D, Vandenbroucke JP, Breedveld FC, Hazes JM (1994) Sociodemographic factors and the outcome of rheumatoid arthritis in young women. Ann Rheum Dis 53:803–806PubMedCrossRef
30.
Zurück zum Zitat Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH (2002) Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 31:355–360PubMedCrossRef Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH (2002) Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 31:355–360PubMedCrossRef
31.
Zurück zum Zitat Hajeer AH, Dababneh A, Makki RF, Thomson W, Poulton K, González-Gay MA et al (2000) Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. Tissue Antigens 55:319–325PubMedCrossRef Hajeer AH, Dababneh A, Makki RF, Thomson W, Poulton K, González-Gay MA et al (2000) Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. Tissue Antigens 55:319–325PubMedCrossRef
32.
Zurück zum Zitat Gonzalez-Gay MA, Hajeer AH, Dababneh A, Makki R, Garcia-Porrua C, Thomson W et al (2001) Seronegative rheumatoid arthritis in elderly and polymyalgia rheumatica have similar patterns of HLA association. J Rheumatol 28:122–125PubMed Gonzalez-Gay MA, Hajeer AH, Dababneh A, Makki R, Garcia-Porrua C, Thomson W et al (2001) Seronegative rheumatoid arthritis in elderly and polymyalgia rheumatica have similar patterns of HLA association. J Rheumatol 28:122–125PubMed
33.
Zurück zum Zitat González-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE (2003) Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 33:38–48PubMedCrossRef González-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE (2003) Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 33:38–48PubMedCrossRef
34.
Zurück zum Zitat Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911–920PubMedCrossRef Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911–920PubMedCrossRef
35.
Zurück zum Zitat Inman RD (1991) Infectious etiology of rheumatoid arthritis. Rheum Dis Clin North Am 17:859–870PubMed Inman RD (1991) Infectious etiology of rheumatoid arthritis. Rheum Dis Clin North Am 17:859–870PubMed
36.
Zurück zum Zitat Toussirot E, Roudier J (2008) Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol 22:883–896PubMedCrossRef Toussirot E, Roudier J (2008) Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol 22:883–896PubMedCrossRef
Metadaten
Titel
Combined influence of genetic and environmental factors in age of rheumatoid arthritis onset
verfasst von
Luis Rodríguez-Rodríguez
José Ramón Lamas
Jezabel Varadé
Pilar Tornero-Esteban
Lydia Abasolo
Emilio Gomez de la Concha
Juan Angel Jover
Elena Urcelay
Benjamín Fernández-Gutiérrez
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 10/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2090-9

Weitere Artikel der Ausgabe 10/2012

Rheumatology International 10/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.